AvKARE recalls Atovaquone Oral Suspension USP
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
- Products
-
- Atovaquone Oral Suspension USP
- Company
- AvKARE
- Where it was sold
-
US Nationwide.
Nationwide
- Units affected
- 153 cartons
- About this recall
- Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.